- This event has passed.
Duke team part of new peer-reviewed publication which adds support for IGFBP7 as a therapeutic target in ALS.
September 13, 2025 All day
Duke team part of new peer-reviewed publication which adds support for IGFBP7 as a therapeutic target in ALS.
This is the first target that came out of the “ALS Reversals” research!
You can read it free HERE
